Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Wearable Hormone Monitor Enables At-Home Detection of Primary Aldosteronism

By HospiMedica International staff writers
Posted on 28 Aug 2026

Primary aldosteronism, a hormone disorder that affects up to one in five people with hypertension, increases risks of heart disease, stroke and diabetes. More...

Many cases are missed because routine testing is infrequent and hormone levels fluctuate over the day and night. Delayed or absent diagnosis leaves patients exposed to preventable cardiovascular harm. A new study shows that continuous, at-home hormone monitoring with a wearable can uncover hidden spikes that signal the condition earlier.

Researchers at the University of Bristol developed the U-RHYTHM wearable and evaluated it with collaborators at the University of Manchester, the University of Bergen, and partner institutions in Stockholm and Athens. The system enables 24-hour hormone profiling during normal daily activities, with the goal of revealing disease-related hormonal rhythms that conventional clinic-based testing may miss.

U-RHYTHM is a lightweight, waist-worn device about the size of a mobile phone. It samples hormones from the skin every 20 minutes while patients continue their usual activities and sleep overnight. This continuous sampling generates circadian hormone profiles that can then be analyzed computationally to identify abnormal patterns over time.

In a proof-of-concept study, 60 patients from Bristol, Bergen, Stockholm, and Athens were monitored over a single 24-hour period. Researchers tracked aldosterone together with the related steroids 18-hydroxycortisol and 18-oxocortisol. Rather than remaining persistently elevated, hormone levels showed repeated nocturnal bursts and daytime surges.

These fluctuations may help explain why single-time-point blood tests can miss cases and were most pronounced when disease involved only one adrenal gland. In patients with unilateral disease, the abnormal hormone pattern disappeared after surgical removal of the affected gland, supporting a direct link between the rhythm and the disorder. The findings were published in Science Translational Medicine in August 2026. The technology was adopted and further developed by the spinout company Dynamic Therapeutics in 2023.

“Primary aldosteronism is an important cause of high blood pressure and the most common cause of secondary hypertension we see in our blood pressure clinic. It could be affecting millions of people in the UK. However, due to the way hormones change during the day and the current complexity of the diagnostic process, diagnosis is often delayed or never made at all. In our study, patients were monitored at home during normal activity, and this allowed us to see how hormones changed over time in realistic settings. This approach could potentially revolutionize how we diagnose hypertension and ultimately reduce cardiovascular disease—particularly heart disease and strokes—that could have been prevented,” said Dr. Thomas Upton, clinical research fellow in automated sampling, clinical fellow at the University of Bristol and senior clinical fellow at Bristol Hospitals NHS Foundation Trust.

“By continuously monitoring hormones over 24 hours, we were able to reveal a previously hidden pattern of nocturnal hormone bursts. This gives us a much clearer understanding of the disease and could ultimately help doctors detect it earlier and treat patients more effectively. A more detailed mathematical and computational analysis of daily hormonal profiles could eventually also help uncover earlier and more subtle forms of the disease, opening new opportunities to improve outcomes for patients living with high blood pressure,” said Dr. Eder Zavala, UKRI Future Leader Fellow at the University of Manchester.

Related Links
University of Bristol 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Gold Member
Blood Gas Analyzer
i-Check200
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.